These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8338929)

  • 1. The excess risk of treated end-stage renal disease in blacks in the United States.
    Lopes AA; Port FK; James SA; Agodoa L
    J Am Soc Nephrol; 1993 Jun; 3(12):1961-71. PubMed ID: 8338929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.
    Lopes AA; Hornbuckle K; James SA; Port FK
    Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
    Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus, by race/ethnicity--Colorado, 1982-1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(44):845-8. PubMed ID: 1435671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-stage renal disease and race: an overview and perspective.
    Ferguson R
    J Natl Med Assoc; 1991 Sep; 83(9):794-8. PubMed ID: 1942113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conundrum of increased burden of end-stage renal disease in Asians.
    Hall YN; Hsu CY; Iribarren C; Darbinian J; McCulloch CE; Go AS
    Kidney Int; 2005 Nov; 68(5):2310-6. PubMed ID: 16221234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup.
    Rocco MV; Frankenfield DL; Frederick PR; Pugh J; McClellan WM; Owen WF
    Perit Dial Int; 2000; 20(3):328-35. PubMed ID: 10898051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
    Hsu CY; Lin F; Vittinghoff E; Shlipak MG
    J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
    Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality of blacks and whites with end-stage renal disease attributed to hypertension.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):27-31. PubMed ID: 1442772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
    Lopes AA
    Adv Ren Replace Ther; 2004 Jan; 11(1):14-23. PubMed ID: 14730535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease.
    Derose SF; Rutkowski MP; Levin NW; Liu IL; Shi JM; Jacobsen SJ; Crooks PW
    Kidney Int; 2009 Sep; 76(6):629-37. PubMed ID: 19516247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
    Jovanovich A; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):640-7. PubMed ID: 22383748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study.
    Bock F; Stewart TG; Robinson-Cohen C; Morse J; Kabagambe EK; Cavanaugh KL; Birdwell KA; Hung AM; Abdel-Kader K; Siew ED; Akwo EA; Blot WJ; Ikizler TA; Lipworth L
    BMC Nephrol; 2019 Aug; 20(1):308. PubMed ID: 31390993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.